Mirum Pharmaceuticals, Inc. Common Stock (MIRM) Financials
Key financial figures for Mirum Pharmaceuticals, Inc. Common Stock (Q1 2026).
- Revenue
- $160M
- Net Income
- -$790M
- EPS
- $-13.43
- Total Assets
- $891M
- Operating Cash Flow
- -$229M
Full income statement, balance sheet, and cash flow for Mirum Pharmaceuticals, Inc. Common Stock on SentiSense.